Citi rates XRO a Buy
Xero's FY17 financial performance turned out better than expected. The analysts note the implied 2H EBITDA loss of just -$2.7m was significantly better than market's and Citi's expectations.
Citi analysts predict a mild upgrade to market consensus projections, labeling the performance as "encouraging". Citi anticipates Xero to achieve cashflow breakeven position in FY18.
Xero's growth in Australia/New Zealand was above expectations and the analysts once again repeat their mantra it is their assessment both Xero and competitor both MYOB ((MYO)) should continue to see solid growth in Aust/NZ subscribers.
Buy/High Risk rating retained. Price target NZ$24.30.
Forecast EPS FY18 of -21.34 cents & FY19 of 9.63 cents
Citi rates XRO a Buy Xero's FY17 financial performance turned...
Add XRO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$143.19 |
Change
1.490(1.05%) |
Mkt cap ! $21.86B | |||
| Open | High | Low | Value | Volume |
| $140.09 | $143.60 | $139.72 | $50.00M | 350.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 880 | $143.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $143.60 | 879 | 1 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| XRO (ASX) Chart |